32.3 C
New York
Thursday, July 3, 2025

Tag: LGL HEA

PEPG Investors Have the Opportunity to Lead the PepGen Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In PepGen To Contact Him Directly To Discuss...

DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of McLaren Health Care Customers Whose Data May Have Been Compromised

NEWTOWN, Pa., June 23, 2025 /PRNewswire/ -- The law firm of Edelson Lechtzin LLP is investigating data privacy claims regarding an incident at McLaren Health...

Wisner Baum: Ninth Circuit Affirms Actos RICO Class Action Certification Against Takeda and Eli Lilly

Appellate Court upholds decision in first-ever non-settlement national RICO class action lawsuit certified against a major pharmaceutical company, with potential damages exceeding $7 billion. SAN...

PEPG Investor Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against PepGen Inc.

SAN DIEGO, June 12, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise...

DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Shelby Dermatology d/b/a Dermatologists of Birmingham Clients Whose Data May Have Been...

NEWTOWN, Pa., June 11, 2025 /PRNewswire/ -- The law firm of Edelson Lechtzin LLP is investigating data privacy claims regarding an incident at Shelby...

DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Select Medical Holdings Corporation Customers Whose Data May Have Been Compromised

NEWTOWN, Pa., June 9, 2025 /PRNewswire/ -- Edelson Lechtzin LLP, a national class action law firm, is investigating claims regarding data privacy violations at...

The Gross Law Firm Notifies UroGen Pharma Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline – URGN

NEW YORK, June 5, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of UroGen Pharma Ltd. (NASDAQ: URGN). ...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsLGL HEA